Physician's Weekly

JUNE 18, 2025

WEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics , a gene-editing startup, for about $1 billion upfront. Verve is developing a new class of gene-editing drugs that could be given just once to treat chronic conditions. The deal, announced June 17, includes a cash offer of $10.50

Chronic Condition 52

Chronic Condition Diabetes Clinic Patients 52

PEMBlog

JANUARY 21, 2025

Diagnostic Costs : Influenza rapid diagnostic tests: $100-$200 Risk Stratification : Young children (<5 years), particularly those <2 years, and children with chronic conditions such as asthma or immunosuppression, are at higher risk for severe outcomes. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.Available

Clinic 52

Clinic Complication Diagnosis Illness 52

GeriPal

JANUARY 23, 2025

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. Eric 20:51 And your deprescribing was on hospital discharge.

Specialization 119

Specialization IT Patient-Centered Medical 119

Doctor On Demand

APRIL 28, 2025

In fact, most sore throat symptoms resolve in three days for 60-70% of patients, according to March 2025 UpToDate, an evidence-based clinical decision support system used by healthcare professionals. Paramedics can provide life-saving treatment on the way to the hospital. due to chemotherapy, diabetes, or autoimmune disease)?

ER 52

ER Telehealth Primary Care Doctor Appointment 52